Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Spark Capital Advisors(India) Private Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aurobindo Pharma Ltd Approves Acquisition Of Hyacinths Pharma-Business Standard


Thursday, 12 Sep 2013 10:19am EDT 

Business Standard reported that Aurobindo Pharma Ltd has approved to acquire Andhra Pradesh based Hyacinths Pharma, from its existing shareholders. The Company's board also approved the to acquire 25% stake in Silicon Life Sciences from the existing shareholder, ABS Mercantiles Pvt Ltd, it added. Post this acquisition, the equity holding of the Company would increase to 100%, thereby making Silicon a wholly owned subsidiary of the Company. The Company, did not disclose financial details. 

Company Quote

964.35
-3.9 -0.40%
10:15am EDT